Compacted Hemostatic Cellulosic Aggregates
US-2024173457-A1 · May 30, 2024 · US
US9247941B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9247941-B2 |
| Application number | US-201113695493-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2011 |
| Priority date | Apr 30, 2010 |
| Publication date | Feb 2, 2016 |
| Grant date | Feb 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Implants include a film layer containing cellulose secured to a surface of the porous layer that also contains cellulose, wherein the film layer is secured to the porous cellulose without the use of an adhesive.
Opening claim text (preview).
What is claimed is: 1. A process for forming a medical device comprising: approximating a film layer comprising cellulose fibers and a porous layer comprising cellulose fibers; contacting the approximated film layer and porous layer with a solvent suitable for swelling cellulose to join the film layer and porous layer to form the medical device as a multi-layered substrate without the use of an adhesive, wherein the medical device is an implantable hemostat and the film layer is bound to a surface of the porous layer by intertwined cellulose fibers of the film layer and the porous layer. 2. A process according to claim 1 , further comprising oxidizing the multi-layered substrate. 3. A process according to claim 2 , wherein oxidizing comprises exposing the multi-layered substrate to an oxidation medium. 4. A process according to claim 3 , wherein oxidizing comprises exposing the multi-layered substrate to nitrogen dioxide dissolved in densified carbon dioxide. 5. A process according to claim 3 , wherein oxidizing comprises exposing the multi-layered substrate to densified fluid selected from the group consisting of nitrogen dioxide and carbon dioxide. 6. A process according to claim 5 , wherein the densified fluid is a supercritical fluid. 7. A process according to claim 1 , wherein contacting the approximated film layer and porous layer with a solvent suitable for swelling cellulose comprises contacting the approximated film layer and porous layer with a basic solution including a base selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, or combinations thereof. 8. A process according to claim 1 , further comprising washing the multi-layered substrate to remove the solvent. 9. A process according to claim 1 , further comprising sterilizing the multi-layered substrate. 10. The process of claim 1 , wherein contacting the approximated film layer and porous layer with a solvent suitable for swelling cellulose comprises contacting the approximated film layer and porous layer with a solution of sodium hydroxide at a concentration from 1.5N to 2.5N. 11. The process of claim 10 , wherein the solution of sodium hydroxide includes a ratio of water and alcohol ranging from about 3/97 to 20/80 (w/w). 12. The process of claim 1 , wherein contacting the approximated film layer and porous layer with a solvent suitable for swelling cellulose comprises contacting the approximated film layer and porous layer with a solution of sodium hydroxide at a concentration of 2N. 13. The process of claim 12 , wherein the solution of sodium hydroxide includes a ratio of water and alcohol ranging from about 10/90 (w/w). 14. The process of claim 1 , wherein the film layer comprising cellulose and the porous layer comprising cellulose are both pre-formed prior to approximating. 15. A medical device comprising: a porous layer comprising cellulose fibers; and a film layer comprising cellulose fibers secured to a surface of the porous layer, wherein the film layer is secured to the porous layer without the use of an adhesive, wherein the medical device is an implantable hemostat and the film layer is bound to a surface of the porous layer by intertwined cellulose fibers of the film layer and the porous layer. 16. A medical device according to claim 15 , wherein the film layer consists essentially of cellulose. 17. A medical device according to claim 15 wherein the porous layer comprises a textile made entirely of fibers consisting essentially of cellulose. 18. The medical device of claim 15 , wherein the implantable hemostat consists essentially of the porous layer comprising cellulose and the film layer comprising cellulose. 19. The medical device of claim 18 , wherein the porous layer comprising cellulose is configured to absorb bodily fluids upon implantation and the film layer comprising cellulose is configured to prevent the absorbed bodily fluids from spreading.
Polysaccharides or their derivatives {(A61L15/225 takes precedence)} · CPC title
Porous materials, e.g. foams or sponges · CPC title
Wound clamps {or clips, i.e. not or only partly penetrating the tissue (suture bridges A61B17/0466); Devices for bringing together the edges of a wound} · CPC title
Materials for stopping bleeding · CPC title
Cellulose; Modified cellulose · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.